Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) June 10, 2025
FAN Xue-jiao, REN Peng-liang, LU Zhong-jiao, et al. The Study of Esophageal Cancer Risk Associated with Polymorphisms of DNA Damage Repair Genes XRCC4 and RAD51[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(4): 568-572.
Citation: FAN Xue-jiao, REN Peng-liang, LU Zhong-jiao, et al. The Study of Esophageal Cancer Risk Associated with Polymorphisms of DNA Damage Repair Genes XRCC4 and RAD51[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(4): 568-572.

The Study of Esophageal Cancer Risk Associated with Polymorphisms of DNA Damage Repair Genes XRCC4 and RAD51

More Information
  • Received Date: December 23, 2012
  • Revised Date: April 08, 2013
  • Published Date: July 19, 2013
  • Objective Investigate the association between genetic polymorphism of DSBs repair gene XRCC4, RAD51 and susceptibility to esophageal cancer (EC). Methods A hospital based case-control study with 123 EC cases and 61 controls in a Chinese population was conducted. PCR-RFLP was applied to investigate the genotype of XRCC4 promoter G-1394T (rs6869366) and RAD51-G135C and then statistical analysis was conducted by calculating the adjusted odds ratios (OR) and 95% confidence intervals (95%CI). Results A significant difference of XRCC4-1394 polymorphism was observed between EC cases and controls (P<0.05). Carriers of the XRCC4 rs6869366 G allele (GC+GG) were at a higher risk of developing EC with the TT genotype as reference (OR=3.022, 95%CI=1.487-6.142, P=0.002). When GG served as the reference group of RAD51-G135C allele, variant genotype (GC and CC) had a significant increased risk of lung cancer (OR=3.643,95%CI=1.501-8.842,P<0.05). Conclusion Our findings indicated that genetic variants in DNA repair pathways may be involved in esophageal tumorigenesis. XRCC4 G-1394T and RAD51-G135C conferred risk for the process of developing EC.
  • [1]
    Xing D, Tan W, Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep,2003;10(5):1615-1623.
    [2]
    Hiyama T, Yoshihara M, Tanaka S, et al. Genetic polymorphisms and esophageal cancer risk. Int J Cancer,2007;121(8):1643-1658.
    [3]
    Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev,2002;11(12):1513-1530.
    [4]
    Qiao GB, Wu YL, Yang XN, et al. High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients.Br J Cancer,2005;93(1):137-143.
    [5]
    Rollinson S, Smith AG, Allan JM, et al. RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia. Leuk Res,2007;31(2):169-174.
    [6]
    Poplawski T, Arabski M, Kozirowska D, et al. DNA damage and repair in gastric cancer——a correlation with the hOGG1 and RAD51 genes polymorphisms.Mutat Res,2006;601(1-2):83-91.
    [7]
    Richardson C, Stark JM, ommundsen M, et al. Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability.Oncogene,2004;23(2):546-553.
    [8]
    Bhatla D, Gerbing RB, Alonzo TA, et al.DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia:a report from the Children's Ontology Group.Leukemia,2008;22(2):265-272.
    [9]
    Sung, P, Klein H. Mechanism of homologous recombination:mediators and helicases take on regulatory functions.Nat Rev Mol Cell Biol,2006;7(10):739-750.
    [10]
    杨乐平, 谭兴国, 杨竹林等.胰腺癌大鼠RAD51和MAX的表达. 中南大学学报,2010;35(2):146-151.
    [11]
    Schwendener S, Raynard S, Paliwal S, et al.Physical interaction of RECQ5 helicase with RAD51 facilitates its anti-Recombinase activity.J Biol Chem,2010;285(21):15739-15745.
    [12]
    Liu Y, Maizels N. Coordinated response of mammalian Rad51 and Rad52 to DNA damage. EMBO Rep,2000;1(1):85-90.
    [13]
    Jara L, Acevedo ML, Blanco R, et al. RAD51135G>C polymorphism and risk of familial breast cancer in a South American population.Cancer Genet Cytogenet,2007;178(1):65-69.
    [14]
    Flygare J, Falt S, Ottervald J, et al. Effects of HsRad51 overexpression on cell Proliferation, cell cycle progression, and apoptosis. Exp Cell Res,2001;268(1):61-69.
    [15]
    Raderschell E, Stout K. Elevated levels of Rad51 recombination protein in tumor cells.Cancer Res,2002;62(1):219-225.

Catalog

    Article views (3359) PDF downloads (31) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return